Biopharm Company News - BioPharm International


Biopharm Company News
News from biopharmaceutical companies, including mergers, acquisitions, drug approvals, drug recalls.

BMS Recalls Coumadin Vials Due to Particulate Matter

July 1, 2014

Bristol-Myers Squibb issues a voluntary US recall of Coumadin (warfarin sodium) for injection due to presence of particulate matter.

EMD Serono and Mersana to Develop Next-Generation Antibody-Drug Conjugates

July 1, 2014

The collaboration will use Mersana Therapeutics Fleximer technology for antibody-drug conjugates.

GSK Offers $1 Million Award for Healthcare Innovations

June 29, 2014

GSK and Save the Children announce criteria for awards that recognize innovation in healthcare for the world"s poorest children.

Cytovance Biologics Manufactures AM0010 for ARMO BioSciences

June 29, 2014

Cytovance Biologics completes GMP manufacture of ARMO BioSciences' lead product.

Medicenna Therapeutics Selects Kalon Biotherapeutics To Manufacture New Cancer Drug

June 26, 2014

Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.

Shire Confirms Rejection of AbbVie Proposal

June 20, 2014

Shire reports that AbbVie offer undervalued company.

Hospira Issues Recall Due to Visible Particulates in Vials

June 18, 2014

Hospira announces a voluntary nationwide recall due to particulates from a glass defect.

FDA Licenses First US Facility for Cell-Culture Influenza Vaccines

June 16, 2014

Novartis facility becomes the first US site licensed by the FDA to produce cell-culture influenza vaccines.

Glenmark Pharmaceuticals Opens Monoclonal Antibody Manufacturing Facility

June 12, 2014

The new mAb manufacturing facility in Switzerland will supply material for clinical development.



Click here